US FDA bans more products from Ranbaxy
In another setback to Ranbaxy, the US drug regulator has prohibited the Indian drugmaker from producing and distributing drugs for the US market from its Toansa facility in Punjab. The US Food and Drug Administration (FDA) Thursday notified Ranbaxy Laboratories Ltd that its facility in Toansa had been added to the consent decree of permanent […]